16 Mar, 2019

eLearning Evolves into Multimodal Digital Learning in 2019

March 16th, 2019|Categories: Blog|

The word “eLearning” has come so far since it was first coined in 1999.[1] Twenty years later, eLearning reaches far beyond the confines of the simple lowercase “e” for electronic. It is highly adaptable, often social and usually competitive. Continuing technological advances in virtual reality, augmented reality, artificial intelligence, and more are transforming the learning [...]

31 Jan, 2019

Pharma Trends: What to Expect in 2019

January 31st, 2019|Categories: Blog|

Trends to watch in 2019 include an increasing emphasis on highly targeted drugs; new healthcare applications for artificial intelligence (AI) and machine learning (ML); eMeeting innovations; and pressure to reduce drug prices while improving patient outcomes. The following is a round-up of what we’re expecting to see this year: Outcome-Based Care Payers, healthcare professionals and [...]

10 Jan, 2019

The FDA’s Streamlined Drug Approval Process: What You Need to Know

January 10th, 2019|Categories: Blog|

Major news from 2018 was the FDA’s announcement of upcoming changes to  the processes of the drug review office. Included in the modernization, per a written statement[1] from the FDA Commissioner Scott Gottlieb, is to provide FDA scientists and medical officers the opportunity to become “thought leaders”[2] in their fields. The proposals for change include [...]

10 Dec, 2018

The International Society for Pharmaceutical Engineering (ISPE) Foundation Set to Enhance the Future of Pharma Industry


December 10th, 2018|Categories: Blog|

Having worked with pharmaceutical clients for more than a decade, the team at Six Degrees Medical understands the incredible pace of change inherent in the industry. Ongoing changes to regulations, new research and revolutionary new treatment methods require organizations like the ISPE to prioritize innovation. With this in mind, the ISPE has launched a philanthropic [...]

14 Nov, 2018

Will Brexit Create Undue Disruptions to Medical Supply in the UK?

November 14th, 2018|Categories: Blog|

As the UK prepares to exit the European Union, regulatory responsibilities for medication manufacturers are shifting. Companies potentially affected by Brexit need to ensure that their marketing authorisation remains valid in the coming months. A recent survey[1] conducted by the European Medicines Agency (EMA) showed that 58% of marketing authorisation holders with regulatory ties in [...]

14 Nov, 2018

eConnext™: Revolutionize Your Virtual Meetings

November 14th, 2018|Categories: Blog|

You are busy. Your stakeholders are busy. Your target audience is busy. While nothing will ever replace the value of a face-to-face meeting, the pace of life today demands a more convenient and cost-effective solution. Sure, there are plenty of virtual meeting platforms available, but until now, no platform has been able to meet the [...]

15 Aug, 2018

Developing Key Messaging for Medical Solutions: Notes from the 2018 DIA

August 15th, 2018|Categories: Blog|

The Drug Information Association (DIA) provides a global stage for the discussion of healthcare challenges, within a collaborative and neutral setting. For more than 50 years, stakeholders from around the world have gathered to openly share knowledge and generate new insights. The annual DIA Global Annual Meeting is the largest, longest-running event in the life [...]

3 Jul, 2018

Increased Efficiency of Clinical Trials in the EU

July 3rd, 2018|Categories: Blog|

Researchers, stakeholders, and corporate interests reached consensus in 2014 that there needed to be greater harmony of the rules for conducting clinical trials throughout the EU. While there were previous guidelines in place (namely the EU Clinical Trials Directive, which was approved in 2001), member states had interpreted and implemented the rules differently throughout the [...]

28 May, 2018

The Advisory Board “Laboratory” for Key Message Development

May 28th, 2018|Categories: Blog|

Medical advisory boards are instrumental in helping companies develop key scientific messages that address unmet needs and best communicate new clinical trial findings. They have become an essential resource for pharmaceutical companies in providing thought leadership, subject matter expertise and scientific direction. By their very design, based on a conversational approach, advisory boards provide key [...]

9 May, 2018

New EU Data Protection Regulation Poised to Change Data Privacy Landscape

May 9th, 2018|Categories: Blog|

The bold digital clock featured on the EUGDPR (EU General Data Protection Regulation)1 website indicates – to the second – the countdown to the regulation’s May 25, 2018 enforcement date. The site communicates the sense of urgency and importance of the initiative which it heralds as “the most important change in data privacy regulation in [...]